Hemogenyx Pharmaceuticals Plc (HOPHF)

Hemogenyx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10	18	34	16	25	57
Market Cap Growth	-48.41%	-48.41%	120.18%	-37.12%	-56.46%	512.38%
Enterprise Value	14	19	35	9	13	55
Last Close Price	1.24	1.24	16.00	5.64	11.72	52.00
PB Ratio	9.81	16.63	9.72	4.00	2.25	47.79
P/TBV Ratio	19.94	33.78	11.51	4.58	2.37	65.81
Debt / Equity Ratio	3.07	3.07	1.06	1.06	0.00	1.86
Quick Ratio	0.14	0.14	1.69	3.40	19.41	1.05
Current Ratio	0.72	0.72	2.93	3.47	20.23	1.08
Return on Equity (ROE)	-309.56%	-309.56%	-222.31%	-69.88%	-112.98%	-795.61%
Return on Assets (ROA)	-65.14%	-65.14%	-61.24%	-44.28%	-30.20%	-72.36%
Return on Capital (ROIC)	-73.03%	-73.03%	-65.22%	-46.57%	-31.63%	-78.78%
Earnings Yield	-67.09%	-39.59%	-24.75%	-30.65%	-27.76%	-4.98%
FCF Yield	-49.59%	-29.26%	-23.02%	-25.72%	-17.77%	-4.71%
Buyback Yield / Dilution	-16.95%	-16.95%	-15.25%	-26.59%	-86.57%	-15.00%

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.